Pancreatic Cancer Research

ResearcherPhilipps University of MarburgActive in the last 2 years

Martin N.J.M. Wasser

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-7020-5242; OpenAlex author ID A5053226901. Sources: OpenAlex.

Their work

Papers
17 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
48
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 4 papers · 2025: 1 paper

Papers 17

  1. Response to letter of the editor ‘Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions’ First author DOI 10.1007/s10689-025-00493-5↗
  2. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Co-author DOI 10.1007/s10689-024-00368-1↗
  3. Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions. Last author DOI 10.1007/s10689-024-00394-z↗
  4. The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1097/mpa.0000000000002335↗
  5. Small Field-of-View T2-Weighted MRI of the pancreas in a Screening Setting for Hereditary Pancreatic Cancer: Improving Image Quality Through Radial K-Space Sam… Last author DOI 10.26502/jrci.2809093↗
  6. Practice variation in venous resection during pancreatoduodenectomy for pancreatic cancer: A nationwide cohort study. Co-author DOI 10.1016/j.surg.2023.06.012↗
  7. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis. Co-author DOI 10.1053/j.gastro.2023.02.032↗
  8. Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study. Co-author DOI 10.1245/s10434-023-13112-3↗
  9. Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up. Co-author DOI 10.1200/jco.22.00194↗
  10. Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis. Co-author DOI 10.1093/bjs/znab345↗
  11. Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillanc… Last author DOI 10.1016/j.hpb.2019.02.013↗
  12. High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. First author DOI 10.1158/1940-6207.capr-18-0035↗
  13. Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer. Co-author DOI 10.1007/s10689-016-9915-3↗
  14. Refinement of screening for familial pancreatic cancer. Co-author DOI 10.1136/gutjnl-2015-311098↗
  15. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. Co-author DOI 10.1200/jco.2015.64.0730↗
  16. Variation in precursor lesions of pancreatic cancer among high-risk groups. Co-author DOI 10.1158/1078-0432.ccr-12-2730↗
  17. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. First author DOI 10.1053/j.gastro.2010.11.048↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bas Boekestijn · 8 shared papers, 2019–2025 · strength 1.84
  2. Bert A. Bonsing · 15 shared papers, 2011–2024 · strength 1.68
  3. Hans F. A. Vasen · 11 shared papers, 2011–2024 · strength 1.08
  4. J. Sven D. Mieog · 7 shared papers, 2021–2024 · strength 1.07
  5. Monique Esther van Leerdam · 5 shared papers, 2022–2024 · strength 0.94
  6. Jeanin Elise van Hooft · 4 shared papers, 2022–2024 · strength 0.70
  7. Derk C.F. Klatte · 4 shared papers, 2022–2024 · strength 0.70
  8. Aleksander M. Bogdanski · 3 shared papers, 2024 · strength 0.68
  9. Thomas P. Potjer · 5 shared papers, 2013–2024 · strength 0.53
  10. Hans Morreau · 7 shared papers, 2011–2023 · strength 0.51
  11. Isaura S. Ibrahim · 6 shared papers, 2016–2022 · strength 0.45
  12. Jesse V. Groen · 3 shared papers, 2021–2023 · strength 0.37
  13. Nynke Michiels · 3 shared papers, 2021–2023 · strength 0.37
  14. Ignace H. J. T. de Hingh · 3 shared papers, 2021–2023 · strength 0.37
  15. Marc G. Besselink · 3 shared papers, 2021–2023 · strength 0.37
  16. Wouter H. de Vos tot Nederveen Cappel · 5 shared papers, 2011–2019 · strength 0.26
  17. Vincent B. Nieuwenhuijs · 2 shared papers, 2021–2023 · strength 0.22
  18. Izaak Quintus Molenaar · 2 shared papers, 2021–2023 · strength 0.22
  19. Vincent Erwin de Meijer · 2 shared papers, 2021–2023 · strength 0.22
  20. Babs M. Zonderhuis · 2 shared papers, 2021–2023 · strength 0.22
  21. Bas Groot Koerkamp · 2 shared papers, 2021–2023 · strength 0.22
  22. Judith de Vos‐Geelen · 2 shared papers, 2021–2023 · strength 0.22
  23. Hjalmar C. van Santvoort · 2 shared papers, 2021–2023 · strength 0.22
  24. Martijn W.J. Stommel · 2 shared papers, 2021–2023 · strength 0.22
  25. Casper H.J. van Eijck · 2 shared papers, 2021–2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.